WELLS FARGO & COMPANY/MN - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 25 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$03000.0%0.00%
Q2 2019$03000.0%0.00%
Q1 2019$03000.0%0.00%
Q4 2018$0
-100.0%
300
-70.7%
0.00%
Q3 2018$2,000
-80.0%
1,0240.0%0.00%
Q2 2018$10,000
+42.9%
1,0240.0%0.00%
Q1 2018$7,000
+75.0%
1,024
+110.3%
0.00%
Q4 2017$4,000
-20.0%
4870.0%0.00%
Q3 2017$5,000
+150.0%
487
+160.4%
0.00%
Q2 2017$2,0001870.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders